Andrew Beam is a machine-learning researcher and Chief Technology Officer of 📝Lila Sciences, where he leads its work on AI for scientific discovery. His research spans machine learning, biomedicine and causal inference, with a focus on AI that models complex biological systems. He is a faculty member in epidemiology at the Harvard T.H. Chan School of Public Health, with a secondary appointment at Harvard Medical School.
Beam co-founded NEJM AI, the New England Journal of Medicine publication on how AI is evaluated and adopted in clinical practice, where he serves as deputy editor and co-hosts the NEJM AI Grand Rounds podcast. Before Lila he co-founded Generate:Biomedicines, an early generative-AI platform for protein and therapeutic design, and was a Senior Fellow at 📝Flagship Pioneering leading machine learning across its portfolio. He holds a PhD and MS from North Carolina State University and received a Robert Wood Johnson Foundation Pioneer Award.